PET tracers targeted at C-C chemokine receptor type 5 (CCR5), type 2 (CCR2), and other immune cell chemokine surface receptors have been evaluated in animal models of vascular injury and atherosclerosis [29–32]. The gene discussed is CCR5; the disease is atherosclerosis.